DR. DERVAUX
Sources: the KBO register on 19-11-2026; the National Bank, 2025 annual accounts filed on 24-09-2026; the Belgian Official Gazette, latest deed of 10-05-2023.
Grounds
the facts the verdict rests on, each with its source- DR. DERVAUX made a profit in every financial year since 2008.Annual accounts 2008 to 2025 page 2
- Equity stands at €1.0m, or 96.9% of the balance sheet total of €1.1m. That is more than 95% of the 21,349 companies in the human health sector (NACE 86).Annual accounts 2025 page 2
- DR. DERVAUX paid out €135,723 in dividends, 67% of the profit of 2025.Annual accounts 2025 page 2
- The 2025 accounts reached the National Bank on 24-09-2026, 55 days after the term.National Bank, filing of 24-09-2026 page 5
Representation
Checked did not find the signing rule in the deeds it read.
Ownership
Accounts in the micro format list no shareholders. Checked found none in the deeds or the LEI register either.
Financial situation
Annual accounts 2021 to 2025, as filed with the National Bank
Gross margin and net resultin €m
Equity and debtsin €m
Cashin €m
| Financial year | 2021 | 2022 | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|---|---|
| Results | ||||||
| Gross margin | €312,264 | €213,708 | €245,931 | €318,690 | €302,643 | |
| Operating result | €298,323 | €200,708 | €233,688 | €306,221 | €289,931 | |
| Net result | €208,482 | €141,970 | €162,732 | €213,545 | €203,994 | |
| Balance sheet at the closing date | ||||||
| Equity | €806,120 | €800,959 | €886,388 | €978,148 | €1.0m | |
| Debts | €55,456 | €53,603 | €27,593 | €48,131 | €33,709 | |
| Debts due within one year | €55,456 | €53,603 | €27,593 | €48,131 | €33,709 | |
| Cash | €475,700 | €527,968 | €563,167 | €644,639 | €725,899 | |
| Balance sheet total | €861,576 | €854,561 | €913,981 | €1.0m | €1.1m | |
| Ratios | ||||||
| Solvency | 93.6% | 93.7% | 97.0% | 95.3% | 96.9% | |
| Liquidity | 14.67 | 15.26 | 31.99 | 20.84 | 31.70 | |
Source: Annual accounts 2025, micro format, filed on 24-09-2026 (2026-00525760); Annual accounts 2024, micro format, filed on 24-09-2025 (2025-00505445); Annual accounts 2021 to 2023, filed from 27-09-2022 to 30-09-2024 (2022-20445804, 2023-00470759, 2024-00491855).
Debts fell by €14,422 in 2025.
The 2025 annual accounts state no amount of overdue tax or social security (RSZ) debts.
DR. DERVAUX states no turnover; the micro format does not require it. The gross margin, what is left after purchases, fell from €318,690 to €302,643.
Board, signature and ownership
Position on 19-11-2026 according to the deeds in the Belgian Official Gazette and the annual accounts
Who represents the company
Checked did not find the signing rule in the deeds it read.
Board
one director in officeOwnership and group
Shareholders
Accounts in the micro format list no shareholders. Checked found none in the deeds or the LEI register either.
Board changes
changes role from manager to director. Legal-form conversion: to private limited company. Director discharge: . General meeting of 03-05-2023.
Gazette, deed 23343315appointed as manager. General meeting of 06-06-2017.
Gazette, deed 18181095Holdings
DR. DERVAUX has 1 holding (own 2025 accounts).
| Country | Company | Equity | Result | |
|---|---|---|---|---|
| Belgium 1 | ||||
| BE | 25% | €6,043 | result €19 | |
Source: List of holdings in its own 2025 accounts. Every holding stands with its own latest accounts.
Events and comparison
The last 24 months, newest first
Annual accounts 2025 filed, 55 days late.
NBB filingRegistered in the Peppol Directory. Reachable for e-invoices through 0208:0896696704.
Equity above €1m. Equity rises from €978,148 to €1.0m.
FinancialAnnual accounts 2024 filed, 55 days late.
NBB filingHighest result from 2008 to 2025. The operating result of €306,221 and the net result of €213,545 are both a record.
FinancialComparable companies, two years later
In July 2024, 17,816 companies had the same profile as DR. DERVAUX has now: small, 10 to 20 years old, solvency 30% or more and a profit of 5% of the balance sheet or more. Two years later 96.5% were still trading, 3.2% had stopped another way and 0.3% had gone bankrupt.
In 2025, DR. DERVAUX had a higher net result than 89% of the 21,334 companies in the human health sector (NACE 86).
Other findings
Peppol
Reachable for e-invoices since 27-03-2026, under 0208:0896696704.
Sanctions lists
Sources and method
Where each fact in this report comes from
| Source | What | Date | Reference |
|---|---|---|---|
| KBO register | Registration, legal situation, activity, establishment units | 19-11-2026 | KBO 0896.696.704 |
| National Bank of Belgium | Annual accounts 2025, micro format | 24-09-2026 | 2026-00525760 |
| National Bank of Belgium | Annual accounts 2024, micro format | 24-09-2025 | 2025-00505445 |
| National Bank of Belgium | Annual accounts 2021 to 2023 | 27-09-2022 to 30-09-2024 | 2022-20445804, 2023-00470759, 2024-00491855 |
| Belgian Official Gazette | Board | 10-05-2023 | deed 23343315 |
| Belgian Official Gazette | Board | 19-12-2018 | deed 18181095 |
| Peppol Directory | Registration for e-invoices | 27-03-2026 | 0208:0896696704 |
| Sanctions lists EU, UN, US (OFAC) and UK | Comparison of the name | 16-11-2026 | no match |
| Checked | Checked score, bankruptcy probability, credit, comparable companies | 18-11-2026 | bankruptcy model of 2 October 2026 |
Method
Checked score. A number from 0 to 100. The bankruptcy probability sets the class, from Critical to Excellent; within the class, the comparison with sector peers on solvency, liquidity, profitability and growth counts for half.
Bankruptcy probability. The probability that the company goes bankrupt within 12 months, estimated from the KBO register, the annual accounts and the Gazette with the bankruptcy model of 2 October 2026, computed on 18-11-2026.
Credit. The credit is a tenth of equity, weighted by the score, and never more than a tenth of turnover. With negative equity there is no credit.
Payment terms. Supplier credit is the debt to suppliers divided by the year's purchases, times 365. Customer credit is the same for what customers still owe, against turnover.
Comparable companies. Companies of the same size, age, solvency and profitability at an earlier date, followed two years later in the KBO register and the Gazette.
The scores and ratios are Checked's own calculations, not a credit decision.